Tiger BioSciences Highlights Breakthrough in Placental CAMP Technologies
Tiger BioSciences is showcasing a landmark study initially published in the International Journal of Molecular Sciences. The research examines placental-derived allograft technologies and their potential to revolutionize wound care through enhanced preservation of biological materials.
The human placenta has long been valued for its natural barrier and protective role in wound healing. This study investigates innovations in Cellular and Acellular Matrix-like Products (CAMPs) technology that retain the full three-layer placental membrane and introduces a new four-layer structure that adds an extra amnion. These developments aim to preserve a greater share of the placenta’s native proteins and growth factors.
Key Findings:
- Global protein profiling revealed more than 8,900 proteins linked to tissue repair in advanced CAMPs.
- Both the three-layer and four-layer CAMPs preserved essential proteins under physiological conditions, supporting tissue repair and remodeling.
- Cell-based assays demonstrated the formation of new blood vessel networks, an essential element of wound closure, when either technology served as a protective barrier.
“These results illuminate the intrinsic biological properties of placental CAMPs and their capacity to act as wound coverings while maintaining native features crucial for wound closure,” stated Garrett Ginsfelder, President of Tiger Wound Care. “By conserving native proteins and supporting vascularization, these technologies provide clinicians with powerful tools to address difficult-to-heal wounds.”
The study’s conclusions reinforce Tiger BioSciences’ dedication to advancing allograft science and delivering evidence-based solutions that honor donated tissues while elevating patient care standards.
For the full study, visit https://doi.org/10.3390/ijms262010121 (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4574754-1&h=980777165&u=https%3A%2F%2Fdoi.org%2F10.3390%2Fijms262010121&a=https%3A%2F%2Fdoi.org%2F10.3390%2Fijms262010121)
About Tiger BioSciences
Tiger BioSciences is a vertically integrated cell and tissue technology company deeply involved in every facet of recovery, processing, technology development, R&D, and distribution of cutting-edge Cellular, Acellular, Matrix-like Products (CAMPs). Through its affiliated entities, Tiger BioSciences operates as a tissue recovery organization, a processing and technology innovator, and a trusted collaborator with clinicians.
Reference: Singh, P.; Guha, S.; Landa, O.; King, A.R.; Valdes Cavazos, D.; Marquez, J.; Hill, S. Native Wound-Repair Proteins Retained in Multilayer Placental CAMPs. Int. J. Mol. Sci. 2025, 26, 10121. https://doi.org/10.3390/ijms262010121
